This bill proposes an amendment to the existing law regarding the use of cannabis for therapeutic purposes. Specifically, it seeks to add generalized anxiety disorder to the list of qualifying medical conditions that allow for the legal use of therapeutic cannabis. The bill outlines the addition of a new subparagraph to RSA 126-X:1, IX(b), which would include generalized anxiety disorder as subparagraph (7) following the current subparagraph (6).

The bill has been approved on July 12, 2024, and is set to become effective 60 days after its passage, which would be on September 10, 2024. There are no deletions mentioned in the provided text, only the insertion of generalized anxiety disorder as a new qualifying condition for the therapeutic cannabis program.

Statutes affected:
Introduced: 126-X:1
Version adopted by both bodies: 126-X:1
CHAPTERED FINAL VERSION: 126-X:1